Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy

Antibody Response to COVID-19 mRNA Vaccines in Oncologic and Hematologic Patients Undergoing Chemotherapy

Background: Information on immune responses in cancer patients following mRNA COVID-19 vaccines is still insufficient, but generally, patients had impaired serological responses, especially those with hematological malignancies. We evaluated serological response to COVID-19 mRNA vaccine in cancer pa...

Full description

Bibliographic Details
Main Authors: Manlio Mencoboni, Vincenzo Fontana, Azzurra Damiani, Antonino Spitaleri, Alessandro Raso, Luigi Carlo Bottaro, Giovanni Rossi, Luciano Canobbio, Antonella La Camera, Rosa Angela Filiberti, Paola Taveggia, Alessia Cavo
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Current Oncology
Subjects:
COVID-19
SARS-COV-2
vaccine
cancer
anticancer treatment
seroconversion
Online Access:https://www.mdpi.com/1718-7729/29/5/273

Internet

https://www.mdpi.com/1718-7729/29/5/273

Similar Items